{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T12:34:13Z","timestamp":1720787653605},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T00:00:00Z","timestamp":1381190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s13277-013-1256-3","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T14:21:47Z","timestamp":1381155707000},"page":"1907-1915","source":"Crossref","is-referenced-by-count":18,"title":["XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: A meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Yulan","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morning","family":"Light","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"1256_CR1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3322\/canjclin.56.3.168","volume":"56","author":"C Smigal","year":"2006","unstructured":"Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168\u201383.","journal-title":"CA Cancer J Clin"},{"key":"1256_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"1256_CR3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"1256_CR4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10552-004-1092-2","volume":"15","author":"SR Sturgeon","year":"2004","unstructured":"Sturgeon SR, Schairer C, Grauman D, El Ghormli L, Devesa S. Trends in breast cancer mortality rates by region of the united states, 1950\u20131999. Cancer Causes Control. 2004;15:987\u201395.","journal-title":"Cancer Causes Control"},{"key":"1256_CR5","doi-asserted-by":"crossref","unstructured":"Pei J, Li F, Wang B: Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer. Tumour Biol 2013","DOI":"10.1007\/s13277-013-0997-3"},{"key":"1256_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78\u201385.","journal-title":"N Engl J Med"},{"key":"1256_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.breast.2007.03.004","volume":"16","author":"KL Cheung","year":"2007","unstructured":"Cheung KL. Endocrine therapy for breast cancer: an overview. Breast. 2007;16:327\u201343.","journal-title":"Breast"},{"key":"1256_CR8","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1371\/journal.pmed.0050193","volume":"5","author":"S Silva Idos","year":"2008","unstructured":"Silva Idos S, De Stavola B, McCormack V. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 2008;5:e193.","journal-title":"PLoS Med"},{"key":"1256_CR9","first-page":"1101","volume":"8","author":"K Zaman","year":"2012","unstructured":"Zaman K, Bodmer A, Pralong F, Castiglione-Gertsch M. Breast cancer and obesity, a dangerous relation. Rev Med Suisse. 2012;8:1101\u20134.","journal-title":"Rev Med Suisse"},{"key":"1256_CR10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/annonc\/mdh222","volume":"15","author":"G Berclaz","year":"2004","unstructured":"Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study group experience. Ann Oncol. 2004;15:875\u201384.","journal-title":"Ann Oncol"},{"key":"1256_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-0-387-69080-3_15","volume":"617","author":"SE Hankinson","year":"2008","unstructured":"Hankinson SE. Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer. Adv Exp Med Biol. 2008;617:161\u20139.","journal-title":"Adv Exp Med Biol"},{"key":"1256_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-010-0813-3","volume":"124","author":"LX Qiu","year":"2010","unstructured":"Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, et al. Xpd lys751gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Breast Cancer Res Treat. 2010;124:229\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1073\/pnas.89.1.261","volume":"89","author":"WL Flejter","year":"1992","unstructured":"Flejter WL, McDaniel LD, Johns D, Friedberg EC, Schultz RA. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ercc2 DNA repair gene. Proc Natl Acad Sci U S A. 1992;89:261\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1256_CR14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/2491","volume":"20","author":"F Coin","year":"1998","unstructured":"Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, Egly JM. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet. 1998;20:184\u20138.","journal-title":"Nat Genet"},{"key":"1256_CR15","first-page":"604","volume":"58","author":"MR Shen","year":"1998","unstructured":"Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604\u20138.","journal-title":"Cancer Res"},{"key":"1256_CR16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-010-0863-6","volume":"124","author":"N Pabalan","year":"2010","unstructured":"Pabalan N, Francisco-Pabalan O, Sung L, Jarjanazi H, Ozcelik H. Meta-analysis of two ERCC2 (XPD) polymorphisms, asp312asn and lys751gln, in breast cancer. Breast Cancer Res Treat. 2010;124:531\u201341.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11033-011-0935-7","volume":"39","author":"YM Hussien","year":"2012","unstructured":"Hussien YM, Gharib AF, Awad HA, Karam RA, Elsawy WH. Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients. Mol Biol Rep. 2012;39:1895\u2013901.","journal-title":"Mol Biol Rep"},{"key":"1256_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3892\/ol.2010.220","volume":"2","author":"M Samson","year":"2011","unstructured":"Samson M, Singh SS, Rama R, Sridevi V, Rajkumar T. Xpd lys751gln increases the risk of breast cancer. Oncol Lett. 2011;2:155\u20139.","journal-title":"Oncol Lett"},{"key":"1256_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF03208865","volume":"51","author":"K Jelonek","year":"2010","unstructured":"Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, et al. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010;51:343\u201352.","journal-title":"J Appl Genet"},{"key":"1256_CR20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4077\/CJP.2010.AMK005","volume":"53","author":"HC Wang","year":"2010","unstructured":"Wang HC, Liu CS, Wang CH, Tsai RY, Tsai CW, Wang RF, et al. Significant association of XPD asp312asn polymorphism with breast cancer in Taiwanese patients. Chin J Physiol. 2010;53:130\u20135.","journal-title":"Chin J Physiol"},{"key":"1256_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12253-008-9135-8","volume":"15","author":"VS Syamala","year":"2009","unstructured":"Syamala VS, Syamala V, Sreedharan H, Raveendran PB, Kuttan R, Ankathil R. Contribution of XPD (lys751gln) and XRCC1 (arg399gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report. Pathol Oncol Res. 2009;15:389\u201397.","journal-title":"Pathol Oncol Res"},{"key":"1256_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mrfmmm.2008.09.014","volume":"648","author":"E Synowiec","year":"2008","unstructured":"Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res. 2008;648:65\u201372.","journal-title":"Mutat Res"},{"key":"1256_CR23","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/ijc.23779","volume":"123","author":"P Rajaraman","year":"2008","unstructured":"Rajaraman P, Bhatti P, Doody MM, Simon SL, Weinstock RM, Linet MS, et al. Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists. Int J Cancer. 2008;123:2713\u20136.","journal-title":"Int J Cancer"},{"key":"1256_CR24","first-page":"245","volume":"58","author":"H Romanowicz-Makowska","year":"2007","unstructured":"Romanowicz-Makowska H, Sobczuk A, Smolarz B, Fiks T, Kulig A. Xpd lys751gln polymorphism analysis in women with sporadic breast cancer. Pol J Pathol. 2007;58:245\u20139.","journal-title":"Pol J Pathol"},{"key":"1256_CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12253-008-9034-z","volume":"14","author":"L Kipikasova","year":"2008","unstructured":"Kipikasova L, Wolaschka T, Bohus P, Baumohlova H, Bober J, Blazejova J, et al. Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case\u2013control study. Pathol Oncol Res. 2008;14:131\u20135.","journal-title":"Pathol Oncol Res"},{"key":"1256_CR26","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1158\/1055-9965.EPI-07-0096","volume":"16","author":"KD Crew","year":"2007","unstructured":"Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, et al. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:2033\u201341.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1256_CR27","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/1055-9965.EPI-06-0218","volume":"15","author":"J Shen","year":"2006","unstructured":"Shen J, Desai M, Agrawal M, Kennedy DO, Senie RT, Santella RM, et al. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:1614\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1256_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-006-9364-z","volume":"103","author":"S Costa","year":"2007","unstructured":"Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat. 2007;103:209\u201317.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-006-9263-3","volume":"101","author":"TJ Jorgensen","year":"2007","unstructured":"Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat. 2007;101:65\u201371.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-005-9151-2","volume":"98","author":"T Debniak","year":"2006","unstructured":"Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, et al. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat. 2006;98:209\u201315.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2407-6-114","volume":"6","author":"VU Onay","year":"2006","unstructured":"Onay VU, Briollais L, Knight JA, Shi E, Wang Y, Wells S, et al. SNP\u2013SNP interactions in breast cancer susceptibility. BMC Cancer. 2006;6:114.","journal-title":"BMC Cancer"},{"key":"1256_CR32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/carcin\/bgi330","volume":"27","author":"LE Mechanic","year":"2006","unstructured":"Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case\u2013control study. Carcinogenesis. 2006;27:1377\u201385.","journal-title":"Carcinogenesis"},{"key":"1256_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10549-005-9045-3","volume":"95","author":"AM Brewster","year":"2006","unstructured":"Brewster AM, Jorgensen TJ, Ruczinski I, Huang HY, Hoffman S, Thuita L, et al. Polymorphisms of the DNA repair genes XPD (lys751gln) and XRCC1 (arg399gln and arg194trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat. 2006;95:73\u201380.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR34","doi-asserted-by":"crossref","first-page":"R987","DOI":"10.1186\/bcr1333","volume":"7","author":"K Metsola","year":"2005","unstructured":"Metsola K, Kataja V, Sillanpaa P, Siivola P, Heikinheimo L, Eskelinen M, et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case\u2013control study. Breast Cancer Res. 2005;7:R987\u201397.","journal-title":"Breast Cancer Res"},{"key":"1256_CR35","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1158\/1055-9965.2059.13.12","volume":"13","author":"C Justenhoven","year":"2004","unstructured":"Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, et al. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev. 2004;13:2059\u201364.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1256_CR36","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1158\/1055-9965.2053.13.12","volume":"13","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, et al. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:2053\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1256_CR37","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/bgh167","volume":"25","author":"Q Shi","year":"2004","unstructured":"Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common xpd polymorphisms in breast cancer patients. Carcinogenesis. 2004;25:1695\u2013700.","journal-title":"Carcinogenesis"},{"key":"1256_CR38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1019693504183","volume":"75","author":"D Tang","year":"2002","unstructured":"Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, et al. Polymorphisms in the DNA repair enzyme xpd are associated with increased levels of PAH-DNA adducts in a case\u2013control study of breast cancer. Breast Cancer Res Treat. 2002;75:159\u201366.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"1256_CR40","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"1256_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"1256_CR42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"1256_CR43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics"},{"key":"1256_CR44","doi-asserted-by":"crossref","unstructured":"Zamora-Ros R, Rothwell JA, Scalbert A, Knaze V, Romieu I, Slimani N, Fagherazzi G, Perquier F, Touillaud M, Molina-Montes E, Huerta JM, Barricarte A, Amiano P, Menendez V, Tumino R, de Magistris MS, Palli D, Ricceri F, Sieri S, Crowe FL, Khaw KT, Wareham NJ, Grote V, Li K, Boeing H, Forster J, Trichopoulou A, Benetou V, Tsiotas K, Bueno-de-Mesquita HB, Ros M, Peeters PH, Tjonneland A, Halkjaer J, Overvad K, Ericson U, Wallstrom P, Johansson I, Landberg R, Weiderpass E, Engeset D, Skeie G, Wark P, Riboli E, Gonzalez CA: Dietary intakes and food sources of phenolic acids in the European Prospective Investigation into Cancer and Nutrition (epic) study. Br J Nutr 2013:1\u201312.","DOI":"10.1017\/S0007114513000688"},{"key":"1256_CR45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jech.53.9.583","volume":"53","author":"A Tobias","year":"1999","unstructured":"Tobias A, Campbell MJ. Modelling influenza epidemics in the relation between black smoke and total mortality. A sensitivity analysis. J Epidemiol Community Health. 1999;53:583\u20134.","journal-title":"J Epidemiol Community Health"},{"key":"1256_CR46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10549-009-0693-6","volume":"122","author":"X Ma","year":"2010","unstructured":"Ma X, Qi X, Chen C, Lin H, Xiong H, Li Y, et al. Association between cyp19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls. Breast Cancer Res Treat. 2010;122:495\u2013501.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-009-0471-5","volume":"120","author":"TN Sergentanis","year":"2010","unstructured":"Sergentanis TN, Economopoulos KP. Association of two casp8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;120:229\u201334.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10549-009-0636-2","volume":"121","author":"LX Qiu","year":"2010","unstructured":"Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, et al. Glutathione S-transferase m1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat. 2010;121:703\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10549-009-0722-5","volume":"122","author":"W Yuan","year":"2010","unstructured":"Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, et al. The hOGG1 ser326cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:835\u201342.","journal-title":"Breast Cancer Res Treat"},{"key":"1256_CR50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","volume":"17","author":"S Benhamou","year":"2002","unstructured":"Benhamou S, Sarasin A. ERCC2\/XPD gene polymorphisms and cancer risk. Mutagenesis. 2002;17:463\u20139.","journal-title":"Mutagenesis"},{"key":"1256_CR51","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/aje\/kwj189","volume":"164","author":"M Manuguerra","year":"2006","unstructured":"Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, et al. XRCC3 and XPD\/ERCC2 single nucleotide polymorphisms and the risk of cancer: a huge review. Am J Epidemiol. 2006;164:297\u2013302.","journal-title":"Am J Epidemiol"},{"key":"1256_CR52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7314\/APJCP.2013.14.1.231","volume":"14","author":"QH Yin","year":"2013","unstructured":"Yin QH, Liu C, Hu JB, Meng RR, Li L, Wang YJ. Xpd lys751gln and asp312asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case\u2013control studies. Asian Pac J Cancer Prev. 2013;14:231\u20136.","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1256-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-1256-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1256-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T04:07:53Z","timestamp":1688530073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-1256-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1256"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-1256-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}